|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▼
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
NATALIZUMAB |
L04AG03 |
DE
|
POM
|
11-10-2017 |
|
|
VALID
|
|
NATURAL PHOSPHOLIPIDS |
R07AA02 |
DE
|
POM
|
29-01-2019 |
DE/H/9993/001/ |
05-12-2014 |
VALID
|
|
NETARSUDIL |
S01EX05 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004583 |
19-11-2019 |
VALID
|
|
NINTEDANIB |
L01EX09 |
DE
|
POM
|
26-02-2020 |
|
|
VALID
|
|
NIRAPARIB |
L01XK02 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004249 |
08-01-2018 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
NIVOLUMAB |
L01FF01 |
DE
|
POM
|
|
|
|
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
NOMEGESTROL AND ESTRADIOL |
G03AA14 |
DE
|
POM
|
|
|
|
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
DE
|
POM
|
08-02-2024 |
DE/H/0304/001/ |
10-11-2014 |
VALID
|
|
NORFLOXACIN |
J01MA06 |
DE
|
POM
|
12-07-2022 |
DE/H/2420/001/II/001 |
07-05-2009 |
VALID
|
|
NOSCAPINE |
R05DA07 |
DE
|
POM
|
30-06-2021 |
|
|
VALID
|
|
NUSINERSEN |
M09AX07 |
DE
|
POM
|
|
EMEA/H/C/004312 |
30-05-2017 |
VALID
|
|
OBINUTUZUMAB |
L01FA03 |
DE
|
POM
|
|
|
|
VALID
|
|
ODEVIXIBAT |
A05AX05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
OFATUMUMAB |
L01FA02 |
DE
|
POM
|
|
|
|
VALID
|
|
OFLOXACIN |
J01MA01 |
DE
|
POM
|
12-07-2022 |
DE/H/0317/001/II/013 |
16-11-2009 |
VALID
|
|
OLANZAPINE |
N05AH03 |
DE
|
POM
|
22-09-2017 |
DE/H/4037/004/ |
10-11-2014 |
VALID
|
|
OLAPARIB |
L01XK01 |
DE
|
POM
|
03-02-2021 |
|
|
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
OLMESARTAN MEDOXOMIL |
C09CA08 |
DE
|
POM
|
27-02-2020 |
DE/H/0384/003/ |
19-08-2014 |
VALID
|
|
OLMESARTAN MEDOXOMIL AND AMLODIPINE |
C09DB02 |
DE
|
POM
|
|
|
|
VALID
|
|
OLMESARTAN MEDOXOMIL AND DIURETICS |
C09DA08 |
DE
|
POM
|
07-02-2024 |
|
|
VALID
|
|
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE |
C09DX03 |
DE
|
POM
|
|
|
|
VALID
|
|
OLOPATADINE |
S01GX09 |
DE
|
POM
|
|
|
|
VALID
|
|
OMBITASVIR, PARITAPREVIR AND RITONAVIR |
J05AP53 |
DE
|
POM
|
|
|
|
VALID
|
|
OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
C10AX06 |
DE
|
POM
|
21-08-2018 |
DE/H/3049/001/ |
19-09-2014 |
VALID
|
|
ONDANSETRON |
A04AA01 |
DE
|
POM
|
21-02-2020 |
DE/H/0641/002/ |
11-08-2014 |
VALID
|
|
OPICAPONE |
N04BX04 |
DE
|
POM
|
|
|
|
VALID
|
|
ORITAVANCIN |
J01XA05 |
DE
|
POM
|
01-08-2024 |
|
|
VALID
|
|
OSILODROSTAT |
H02CA02 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004821 |
09-01-2020 |
VALID
|
|
OTHER ANTIINFLAMMATORY / ANTIRHEUMATIC AGENTS IN COMBINATION WITH OTHER DRUGS |
M01BX |
DE
|
POM
|
|
|
|
VALID
|
|
OXCARBAZEPINE |
N03AF02 |
DE
|
POM
|
21-07-2025 |
|
|
VALID
|
|
PACLITAXEL |
L01CD01 |
DE
|
POM
|
|
|
|
VALID
|
|
PADELIPORFIN |
L01XD07 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004182 |
15-11-2017 |
VALID
|
|
PALBOCICLIB |
L01EF01 |
DE
|
POM
|
|
|
|
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PANITUMUMAB |
L01FE02 |
DE
|
POM
|
|
|
|
VALID
|
|
PARECOXIB |
M01AH04 |
DE
|
POM
|
|
|
|
VALID
|
|
PARICALCITOL |
H05BX02 |
DE
|
POM
|
|
|
|
VALID
|
|
PAROXETINE |
N06AB05 |
DE
|
POM
|
26-02-2020 |
DE/H/0574/001/II/004 |
14-11-2007 |
VALID
|
|
PATIROMER CALCIUM |
V03AE09 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/004180 |
19-07-2017 |
VALID
|
|
PAZOPANIB |
L01EX03 |
DE
|
POM
|
26-02-2020 |
|
|
VALID
|
|
PEGASPARGASE |
L01XX24 |
DE
|
POM
|
18-07-2023 |
|
|
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
PEMBROLIZUMAB |
L01FF02 |
DE
|
POM
|
|
|
|
VALID
|
|
PEMETREXED |
L01BA04 |
DE
|
POM
|
14-05-2018 |
DE/H/4233/002/ |
10-12-2015 |
VALID
|
